SCHEMBL8481007

SCHEMBL8481007

OC(COCC1CN(C(c2ccccc2)(c2ccccc2)c2ccccc2)CCO1)c1ccc2ccccc2c1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 4/20 0.41
HRH3 Q9Y5N1 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HTR1A P08908 3/20 0.36
PDK1 Q15118 2/20 0.35
SLC6A3 Q01959 2/20 0.33
AOC3 Q16853 1/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8482170 0.90 HRH3 (0.38) DRD4HRH3PDK1SLC6A3PRMT5
SCHEMBL8482174 0.90 HRH3 (0.38) DRD4HRH3PDK1SLC6A3PRMT5
SCHEMBL8481920 0.87 GRIN2B (0.45) DRD4HRH3AOC3
SCHEMBL8482364 0.82 PDK1 (0.40) DRD4HRH3PDK1PRMT5WDR77
SCHEMBL8482198 0.74 DRD4 (0.44) DRD4KMT2ASLC6A3
SCHEMBL8481010 0.72 SLC6A3 (0.40) DRD4SLC6A3CYP2D6
SCHEMBL8480377 0.71 ADORA2A (0.43) DRD4HRH3PDK1CYP1A2CYP2D6
SCHEMBL27828848 0.71 ADORA2A (0.43) DRD4HRH3PDK1CYP1A2CYP2D6
SCHEMBL8434603 0.71 ADORA2A (0.43) DRD4HRH3PDK1CYP1A2CYP2D6
SCHEMBL8482066 0.69 DRD4 (0.56) DRD4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5872117-A TREATING CEREBROVASCULAR DEMENTIA, SENILE DEMENTIA, ALZHEIMER'S DEMENTIA, SEQUELAE OF ISCHEMIC ENCEPHALOPATHY AND CEREBRAL APOPLEXY TOYAMA CHEMICAL CO., LTD. (JP) 1999-02-16 US disclosed
US-5719150-A ALZHEIMER'S DISEASE TOYAMA CHEMICAL CO., LTD. (JP) 1998-02-17 US disclosed
US-5658904-A COGNITION ACTIVATORS; BRAIN DISORDERS; ALZHEIMER*S DISEASE TOYAMA CHEMICAL CO., LTD. (JP) 1997-08-19 US disclosed
US-5612381-A 1,2-ethanediol derivative and salt thereof process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1997-03-18 US disclosed
EP-0589484-B1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO LTD (JP) 1996-10-16 EP disclosed
US-5472984-A 1,2-ethanediol derivative and salt thereof and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1995-12-05 US disclosed
EP-0589484-A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-30 EP disclosed
EP-0587194-A1 2-(Heterocycloalkoxy)-1-(subst.-phenyl)-ethanol derivatives as cerebral function improving agents TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-16 EP disclosed
EP-0587193-A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-16 EP disclosed
US-5280032-A 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-01-18 US disclosed
EP-0383281-A1 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1990-08-22 EP disclosed